Article

Michael J. Mauro Discusses the Diagnosis of CML

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of melanoma
image of Kelsey Martin
Genetic testing before chemotherapy may help improve safety and guide treatment for patients with gastrointestinal cancers.